| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.084 | 0.05 |